Thermal and oxidative decomposition of Ibuprofen (cas 15687-27-1)-based ionic liquids
-
Add time:09/05/2019 Source:sciencedirect.com
Pharmaceuticals are often discharged into the environment and later detected in drinking water, plants, and soil. Thus, the decomposition or biodegradability of these compounds is a constant concern. The objective of this work was to show the decomposition of pharmaceutical ionic liquids (IL-APIs) via thermal and oxidative methods. Long- and short-term thermal decomposition and oxidative processes in the presence and absence of H2O2 and UV-C irradiation were investigated for four IL-APIs derived from ibuprofen. The results of short-term thermal stability experiments showed that the IL-APIs were thermally stable up to 160–200 °C, and have an activation energy of 60–100 kJ mol−1 for decomposition, which indicates that thermal decomposition requires high energy consumption. Under long thermal stability condition they were stable up to 50 °C; however, they were totally decomposed after 24 h at 100 °C. At 20–40 °C they can take days (t1/2 = 18–72 days) to years (t1/2 = 13–35 years) to be decomposed. On the other hand, oxidative decomposition in water with or without H2O2 (4–12 min and 2–5 h, respectively) was faster, resulting in decomposition of the IL-APIs in minutes to hours. The decomposition products from the oxidative process were characterized by mass spectrometry, which indicated that the presence of H2O2 facilitates an alternative, efficient, and faster method for decomposition of IL-APIs.
We also recommend Trading Suppliers and Manufacturers of Ibuprofen (cas 15687-27-1). Pls Click Website Link as below: cas 15687-27-1 suppliers
Prev:Research paperRepurposing Ibuprofen (cas 15687-27-1) to control Staphylococcus aureus biofilms
Next:Original articleUva-ursi extract and Ibuprofen (cas 15687-27-1) as alternative treatments for uncomplicated urinary tract infection in women (ATAFUTI): a factorial randomized trial) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Preparation and characterization of NiFe2O4/activated carbon composite as potential magnetic adsorbent for removal of Ibuprofen (cas 15687-27-1) and ketoprofen pharmaceuticals from aqueous solutions09/10/2019
- Degradation of Ibuprofen (cas 15687-27-1) by UV-LED/catalytic advanced oxidation process09/09/2019
- Research PaperEvaluation of a modified mica and montmorillonite for the adsorption of Ibuprofen (cas 15687-27-1) from aqueous media09/08/2019
- Brief ObservationAltitude Sickness Prevention with Ibuprofen (cas 15687-27-1) Relative to Acetazolamide09/07/2019
- Original articleUva-ursi extract and Ibuprofen (cas 15687-27-1) as alternative treatments for uncomplicated urinary tract infection in women (ATAFUTI): a factorial randomized trial09/06/2019
- Research paperRepurposing Ibuprofen (cas 15687-27-1) to control Staphylococcus aureus biofilms09/04/2019
- The effects of intra-articular injection of Ibuprofen (cas 15687-27-1) on knee joint cartilage and synovium in rats09/03/2019
- Role of Herborn (K240E) and Milano Slow (D375H) human serum albumin variants towards binding of phenylbutazone and Ibuprofen (cas 15687-27-1)09/02/2019
- Biosorption of Ibuprofen (cas 15687-27-1) using functionalized bean husks09/01/2019
-
Health and Chemical more >